|
|
||||||||
Original Article |
Correspondence to: Clay F. Semenkovich.
Heterozygous lipoprotein lipase deficiency (LPL+/-) is common and has been implicated in premature atherosclerosis in epidemiologic studies. However, in vitro data suggest that LPL deficiency in the vascular wall may be antiatherogenic. To address the role of LPL in atherosclerosis, LPL+/- mice in the C57BL/6J background were fed an atherogenic diet for 8 months. LPL+/- mice were more dyslipidemic than +/+ animals due to increased concentrations of non-HDL lipoproteins. There was no difference in aortic origin atherosclerosis between LPL+/- (n = 56) and +/+ (n = 55) mice. LPL+/- mice in the low density lipoprotein receptor knockout (LDLR-/-) background were fed the same atherogenic diet for 3 months. LPL+/-LDLR-/- mice were more dyslipidemic than LPL+/+LDLR-/- animals. There was no difference in atherosclerosis assayed for the entire aorta and no difference in aortic sterol content between LPL+/-LDLR-/- (n = 28) and LPL+/+LDLR-/- (n = 15) mice. LPL protein was detected in murine lesions in a consistent layered pattern. More luminal, lipid-laden macrophages generally did not stain for LPL, but deeper, lipid-poor macrophages as well as necrotic core regions contained immunoreactive LPL. LPL protein was more abundant in lesions from LPL+/+ LDLR-/- than LPL+/-LDLR-/- mice. After eating an atherogenic diet, LPL+/- as compared to LPL+/+ mice have more dyslipidemia, but no more atherosclerosis, and less LPL protein in atherosclerotic lesions.
These data suggest that lipoprotein lipase deficiency in the vascular wall could prevent the retention of atherogenic lipoproteins. Semenkovich, C. F., T. Coleman, and A. Daugherty. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice. J. Lipid Res. 1998. 39: 11411151.
Supplementary key words: triglyceride, LDL receptor knockout mice, macrophage, vascular wall, cholesterol
This article has been cited by other articles:
![]() |
C. P. Vicente, L. He, and D. M. Tollefsen Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice Blood, December 15, 2007; 110(13): 4261 - 4267. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Schneider, Y. Zhu, T. Coleman, and C. F. Semenkovich Macrophage 3 Integrin Suppresses Hyperlipidemia-Induced Inflammation by Modulating TNF{alpha} Expression Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2699 - 2706. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Qiu and J. S. Hill Endothelial lipase enhances low density lipoprotein binding and cell association in THP-1 macrophages Cardiovasc Res, December 1, 2007; 76(3): 528 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Tordjman, C. F. Semenkovich, T. Coleman, R. Yudovich, S. Bak, E. Osher, M. Vechoropoulos, and N. Stern Absence of Peroxisome Proliferator-Activated Receptor-{alpha} Abolishes Hypertension and Attenuates Atherosclerosis in the Tsukuba Hypertensive Mouse Hypertension, November 1, 2007; 50(5): 945 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tabas, K. J. Williams, and J. Boren Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications Circulation, October 16, 2007; 116(16): 1832 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Khalil, W. D. Wagner, and I. J. Goldberg Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2211 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Beauchamp, S.-E. Michaud, L. Li, M. R. Sartippour, and G. Renier Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression J. Lipid Res., September 1, 2004; 45(9): 1749 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Serri, L. Li, F. Maingrette, N. Jaffry, and G. Renier Enhanced Lipoprotein Lipase Secretion and Foam Cell Formation by Macrophages of Patients with Growth Hormone Deficiency: Possible Contribution to Increased Risk of Atherogenesis? J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 979 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Grenache, T. Coleman, C. F. Semenkovich, S. A. Santoro, and M. M. Zutter {alpha}2{beta}1 Integrin and Development of Atherosclerosis in a Mouse Model: Assessment of Risk Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2104 - 2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Weng, L. Zemany, K. N. Standley, D. V. Novack, M. La Regina, C. Bernal-Mizrachi, T. Coleman, and C. F. Semenkovich {beta}3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice PNAS, May 27, 2003; 100(11): 6730 - 6735. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, R. L. Fitzgerald, J. E. Saffitz, C. F. Semenkovich, and G. Schonfeld Amino Terminal 38.9% of Apolipoprotein B-100 Is Sufficient to Support Cholesterol-Rich Lipoprotein Production and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 668 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Mead and D. P Ramji The pivotal role of lipoprotein lipase in atherosclerosis Cardiovasc Res, August 1, 2002; 55(2): 261 - 269. [Full Text] [PDF] |
||||
![]() |
Y. Kako, M. Masse, L.-S. Huang, A. R. Tall, and I. J. Goldberg Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice J. Lipid Res., June 1, 2002; 43(6): 872 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Beauchamp and G. Renier Homocysteine Induces Protein Kinase C Activation and Stimulates c-Fos and Lipoprotein Lipase Expression in Macrophages Diabetes, April 1, 2002; 51(4): 1180 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Merkel, J. Heeren, W. Dudeck, F. Rinninger, H. Radner, J. L. Breslow, I. J. Goldberg, R. Zechner, and H. Greten Inactive Lipoprotein Lipase (LPL) Alone Increases Selective Cholesterol Ester Uptake in Vivo, Whereas in the Presence of Active LPL It Also Increases Triglyceride Hydrolysis and Whole Particle Lipoprotein Uptake J. Biol. Chem., February 22, 2002; 277(9): 7405 - 7411. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Pentikainen, R. Oksjoki, K. Oorni, and P. T. Kovanen Lipoprotein Lipase in the Arterial Wall: Linking LDL to the Arterial Extracellular Matrix and Much More Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 211 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wilson, G. L. Fry, D. A. Chappell, C. D. Sigmund, and J. D. Medh Macrophage-Specific Expression of Human Lipoprotein Lipase Accelerates Atherosclerosis in Transgenic Apolipoprotein E Knockout Mice but Not in C57BL/6 Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1809 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lin, Z. H. Huang, and T. Mazzone Interaction with proteoglycans enhances the sterol efflux produced by endogenous expression of macrophage apoE J. Lipid Res., July 1, 2001; 42(7): 1125 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Michaud and G. Renier Direct Regulatory Effect of Fatty Acids on Macrophage Lipoprotein Lipase: Potential Role of PPARs Diabetes, March 1, 2001; 50(3): 660 - 666. [Abstract] [Full Text] |
||||
![]() |
M. Van Eck, R. Zimmermann, P. H. E. Groot, R. Zechner, and T. J. C. Van Berkel Role of Macrophage-Derived Lipoprotein Lipase in Lipoprotein Metabolism and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20 (9): e53 - e62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Clee, N. Bissada, F. Miao, L. Miao, A. D. Marais, H. E. Henderson, P. Steures, J. McManus, B. McManus, R. C. LeBoeuf, et al. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis J. Lipid Res., April 1, 2000; 41(4): 521 - 531. [Abstract] [Full Text] |
||||
![]() |
M. O. Pentikainen, K. Oorni, and P. T. Kovanen Lipoprotein Lipase (LPL) Strongly Links Native and Oxidized Low Density Lipoprotein Particles to Decorin-coated Collagen. ROLES FOR BOTH DIMERIC AND MONOMERIC FORMS OF LPL J. Biol. Chem., February 25, 2000; 275(8): 5694 - 5701. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Olin, S. Potter-Perigo, P. H. R. Barrett, T. N. Wight, and A. Chait Lipoprotein Lipase Enhances the Binding of Native and Oxidized Low Density Lipoproteins to Versican and Biglycan Synthesized by Cultured Arterial Smooth Muscle Cells J. Biol. Chem., December 3, 1999; 274(49): 34629 - 34636. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kako, L.-S. Huang, J. Yang, T. Katopodis, R. Ramakrishnan, and I. J. Goldberg Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis J. Lipid Res., December 1, 1999; 40(12): 2185 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Towler, M. Bidder, T. Latifi, T. Coleman, and C. F. Semenkovich Diet-induced Diabetes Activates an Osteogenic Gene Regulatory Program in the Aortas of Low Density Lipoprotein Receptor-deficient Mice J. Biol. Chem., November 13, 1998; 273(46): 30427 - 30434. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Cruz, G. Kwon, C. A. Marshall, M. L. McDaniel, and C. F. Semenkovich Glucose and Insulin Stimulate Heparin-releasable Lipoprotein Lipase Activity in Mouse Islets and INS-1 Cells. A POTENTIAL LINK BETWEEN INSULIN RESISTANCE AND beta -CELL DYSFUNCTION J. Biol. Chem., April 6, 2001; 276(15): 12162 - 12168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Boren, A. Lookene, E. Makoveichuk, S. Xiang, M. Gustafsson, H. Liu, P. Talmud, and G. Olivecrona Binding of Low Density Lipoproteins to Lipoprotein Lipase Is Dependent on Lipids but Not on Apolipoprotein B J. Biol. Chem., July 13, 2001; 276(29): 26916 - 26922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |